Literature DB >> 7535630

Location and anatomical connections of a paradoxical sleep induction site in the cat ventral pontine tegmentum.

F Reinoso-Suárez1, I De Andrés, M L Rodrigo-Angulo, E Rodríguez-Veiga.   

Abstract

The brainstem mechanisms for the generation of paradoxical sleep are under considerable debate. Previous experiments in cats have demonstrated that injections of the cholinergic agonist carbachol into the oral pontine tegmentum elicit paradoxical sleep behaviour and its polygraphic correlates. The different results on the pontine structures that mediate this effect do not agree. We report here that limited microinjections of a carbachol solution into the ventral part of the oral pontine reticular nucleus in the cat induce, with a short latency, a dramatic, long-lasting increase in paradoxical sleep. Moreover, neuronal tracing experiments show that this pontine site is connected with brain structures responsible for the different bioelectric events of paradoxical sleep. These two facts suggest that the ventral part of the oral pontine reticular nucleus is a nodal link in the neuronal network underlying paradoxical sleep mechanisms.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7535630     DOI: 10.1111/j.1460-9568.1994.tb00575.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  12 in total

1.  A quantitative study of the brainstem cholinergic projections to the ventral part of the oral pontine reticular nucleus (REM sleep induction site) in the cat.

Authors:  Margarita Lucía Rodrigo-Angulo; Elisia Rodríguez-Veiga; Fernando Reinoso-Suárez
Journal:  Exp Brain Res       Date:  2004-09-10       Impact factor: 1.972

2.  Eye movements and abducens motoneuron behavior after cholinergic activation of the nucleus reticularis pontis caudalis.

Authors:  Javier Márquez-Ruiz; Miguel Escudero
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

3.  Eye movements and abducens motoneuron behavior during cholinergically induced REM sleep.

Authors:  Javier Márquez-Ruiz; Miguel Escudero
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

Review 4.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

5.  Cholinergic Oculomotor Nucleus Activity Is Induced by REM Sleep Deprivation Negatively Impacting on Cognition.

Authors:  Patrícia Dos Santos; Adriano D S Targa; Ana Carolina D Noseda; Lais S Rodrigues; Juliane Fagotti; Marcelo M S Lima
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

6.  Electron microscopic localization of M2-muscarinic receptors in cholinergic and noncholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei of the rat mesopontine tegmentum.

Authors:  Miguel Garzón; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2016-04-21       Impact factor: 3.215

7.  Neurotoxic N-methyl-D-aspartate lesion of the ventral midbrain and mesopontine junction alters sleep-wake organization.

Authors:  Y Y Lai; T Shalita; T Hajnik; J P Wu; J S Kuo; L G Chia; J M Siegel
Journal:  Neuroscience       Date:  1999-05       Impact factor: 3.590

8.  Synaptic interactions between perifornical lateral hypothalamic area, locus coeruleus nucleus and the oral pontine reticular nucleus are implicated in the stage succession during sleep-wakefulness cycle.

Authors:  Silvia Tortorella; Margarita L Rodrigo-Angulo; Angel Núñez; Miguel Garzón
Journal:  Front Neurosci       Date:  2013-11-19       Impact factor: 4.677

9.  Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis.

Authors:  A Nuñez; M L Rodrigo-Angulo; I De Andrés; M Garzón
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

Review 10.  Evaluating the Evidence Surrounding Pontine Cholinergic Involvement in REM Sleep Generation.

Authors:  Kevin P Grace; Richard L Horner
Journal:  Front Neurol       Date:  2015-09-01       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.